XABT Donates 2019-nCoV Nucleic Acid Detection Kits to Vientiane, Laos

XABT

PR91278

 

BEIJING, Aug. 25, 2021 /PRNewswire=KYODO JBN/ --

 

Atsaphangthong Siphandone, Mayor of Vientiane, the capital of Laos, recently

issued an honorary certificate to Beijing Applied Biological Technologies

(XABT) for the donation of 2019-nCoV Nucleic Acid Detection Kits to support

Vientiane's efforts at epidemic prevention and control in 2021. At the same

time, the deputy director of the Vientiane's foreign affairs office, sent a

letter of thanks to XABT on behalf of the Vientiane Municipal Government and

Epidemic Prevention and Control Committee.

 

During the last coronavirus outbreak in Laos in April this year, XABT donated

5,040 Multiple Real Time PCR Kits for Detection of 2019-nCoV and provided full

technical service support to Vientiane to help the city control the spread of

the disease through in-depth international cooperation.

 

Virus knows no borders, but the worst of times reveals the best in people.

Since the outbreak of COVID-19, XABT has undertaken corporate social

responsibility with practical actions and donated nucleic acid detection and

extraction kits to Italy, Iran, Malaysia, Thailand, Peru and Bangladesh to

support their fights against the epidemic. The company will continue to make

positive contributions to continue the effort at controlling the epidemic

worldwide.  

 

Nucleic acid detection is an important testing and screening method for

2019-nCoV used by the World Health Organization (WHO) and national health

authorities. XABT, among all the companies that have obtained the registration

certificate from the National Medical Products Administration of China for the

coronavirus nucleic acid detection reagent, is one of the few high-tech

companies producing the rapid detection technology covering three genes,

ORF1ab, N and E. The company's 2019-nCoV nucleic acid detection kit

(fluorescence PCR method) can achieve up to 99.9% accuracy due to the specific

binding at the molecular level and was included in the WHO Emergency Use

Listing in May 2020. The company has received the ISO13485 system

certification, and its products, all of which conform to the EU's CE

certification standards, are being adopted by more and more countries as a tool

to control and prevent the further spread of the virus as well as being

recognized as the most effective solution by more and more organizations.

 

For more information:

Company website: http://www.x-abt.com/en/

LinkedIn(

https://www.linkedin.com/company/beijing-applied-biological-technologies-co-ltd/?viewAsMember=true),

Facebook(

https://www.facebook.com/Beijing-Applied-Biological-Technologies-Co-Ltd-105959585091102),

YouTube(

https://studio.youtube.com/channel/UCNCbZZ1J00jieNiPnIZCXGQ/videos/upload?filter=%5B%5D&sort=%7B%22columnType%22%3A%22date%22%2C%22sortOrder%22%3A%22DESCENDING%22%7D)

 

 

SOURCE: XABT

 

Image Attachments Links:

 

   Link: http://asianetnews.net/view-attachment?attach-id=398967

 

 

   Link: http://asianetnews.net/view-attachment?attach-id=398970

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中